Literature DB >> 18976131

Drug delivery strategies for improved azole antifungal action.

Wei Yang1, Nathan P Wiederhold, Robert O Williams.   

Abstract

BACKGROUND: Azole antifungal agents are the most commonly used antifungals in clinical treatment of both superficial and systemic fungal infections. Many azoles are poorly water soluble, which limits their bioavailability and antifungal effects.
OBJECTIVE: To improve the efficacy of azole antifungal drugs by advances in drug delivery.
METHODS: Manipulation of drug formulations and administration routes to improve the antifungal pharmacokinetics with targeted delivery, rapidly followed by sustained release and prolonged retention of high drug concentration localized at the infection site. RESULTS/
CONCLUSION: Formulation and drug delivery strategies can improve the aqueous wetting and dissolution properties by increasing their chemical potential, stabilizing the drug delivery system and targeting high concentration of the azoles to the infection sites, therefore enhancing the bioavailability and therapeutic efficacy of azole antifungals.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18976131     DOI: 10.1517/17425240802457188

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  10 in total

1.  Sustained release of a novel anti-quorum-sensing agent against oral fungal biofilms.

Authors:  Mark Feldman; Julia Shenderovich; Abed Al Aziz Al-Quntar; Michael Friedman; Doron Steinberg
Journal:  Antimicrob Agents Chemother       Date:  2015-02-02       Impact factor: 5.191

2.  Study of in vitro drug release and percutaneous absorption of fluconazole from topical dosage forms.

Authors:  Claudia Salerno; Adriana M Carlucci; Carlos Bregni
Journal:  AAPS PharmSciTech       Date:  2010-06-03       Impact factor: 3.246

3.  A novel sustained-release clotrimazole varnish for local treatment of oral candidiasis.

Authors:  Rakefet Czerninski; Sagi Sivan; Doron Steinberg; Irith Gati; Leonid Kagan; Michael Friedman
Journal:  Clin Oral Investig       Date:  2009-04-29       Impact factor: 3.573

4.  Acanthamoeba Keratitis: an update on amebicidal and cysticidal drug screening methodologies and potential treatment with azole drugs.

Authors:  Brian Shing; Mina Balen; James H McKerrow; Anjan Debnath
Journal:  Expert Rev Anti Infect Ther       Date:  2021-05-19       Impact factor: 5.091

5.  Small, Cationic Antifungal Proteins from Filamentous Fungi Inhibit Candida albicans Growth in 3D Skin Infection Models.

Authors:  Jeanett Holzknecht; Sandrine Dubrac; Sarah Hedtrich; László Galgóczy; Florentine Marx
Journal:  Microbiol Spectr       Date:  2022-05-02

Review 6.  Potential Use of Alginate-Based Carriers As Antifungal Delivery System.

Authors:  Cristina de Castro Spadari; Luciana B Lopes; Kelly Ishida
Journal:  Front Microbiol       Date:  2017-01-30       Impact factor: 5.640

7.  Formulation of Tioconazole and Melaleuca alternifolia Essential Oil Pickering Emulsions for Onychomycosis Topical Treatment.

Authors:  Barbara Vörös-Horváth; Sourav Das; Ala' Salem; Sándor Nagy; Andrea Böszörményi; Tamás Kőszegi; Szilárd Pál; Aleksandar Széchenyi
Journal:  Molecules       Date:  2020-11-26       Impact factor: 4.411

Review 8.  Recent Advances in the Development of Antimicrobial Nanoparticles for Combating Resistant Pathogens.

Authors:  Rajamani Lakshminarayanan; Enyi Ye; David James Young; Zibiao Li; Xian Jun Loh
Journal:  Adv Healthc Mater       Date:  2018-05-02       Impact factor: 9.933

9.  Ultra-deformable liposomes containing terpenes (terpesomes) loaded fenticonazole nitrate for treatment of vaginal candidiasis: Box-Behnken design optimization, comparative ex vivo and in vivo studies.

Authors:  Rofida Albash; Yasmina Elmahboub; Kholoud Baraka; Menna M Abdellatif; Ahmed Adel Alaa-Eldin
Journal:  Drug Deliv       Date:  2020-12       Impact factor: 6.419

Review 10.  Inhaled Antifungal Agents for Treatment and Prophylaxis of Bronchopulmonary Invasive Mold Infections.

Authors:  Kévin Brunet; Jean-Philippe Martellosio; Frédéric Tewes; Sandrine Marchand; Blandine Rammaert
Journal:  Pharmaceutics       Date:  2022-03-14       Impact factor: 6.321

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.